KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Chemed (CHE) EBITDA Margin (2016 - 2025)

Chemed (CHE) has 17 years of EBITDA Margin data on record, last reported at 23.32% in Q4 2025.

  • For Q4 2025, EBITDA Margin rose 97.0% year-over-year to 23.32%; the TTM value through Dec 2025 reached 5.11%, down 52.0%, while the annual FY2025 figure was 5.11%, 52.0% down from the prior year.
  • EBITDA Margin reached 23.32% in Q4 2025 per CHE's latest filing, down from 14.15% in the prior quarter.
  • Across five years, EBITDA Margin topped out at 21.23% in Q4 2023 and bottomed at 33.08% in Q4 2022.
  • Average EBITDA Margin over 5 years is 10.55%, with a median of 16.86% recorded in 2024.
  • Peak YoY movement for EBITDA Margin: skyrocketed 102990bps in 2021, then crashed -5339bps in 2022.
  • A 5-year view of EBITDA Margin shows it stood at 20.31% in 2021, then crashed by -263bps to 33.08% in 2022, then skyrocketed by 164bps to 21.23% in 2023, then tumbled by -214bps to 24.29% in 2024, then increased by 4bps to 23.32% in 2025.
  • Per Business Quant database, its latest 3 readings for EBITDA Margin were 23.32% in Q4 2025, 14.15% in Q3 2025, and 13.21% in Q2 2025.